| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Eastham Karin is a Director at GERN with holdings across 5 companies. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | VCYT Veracyte, Inc. | Director | Sale+OE | 20,000 | $45.45 | $908,923.34 | -26.6% | -22.3% | - | |
| Nov 5, 2025 | VCYT Veracyte, Inc. | Director | Sell | 9,674 | $40.02 | $387,191.21 | -41.6% | -18.0% | - | |
| Jun 13, 2025 | VCYT Veracyte, Inc. | Director | Sell | 4,590 | $26.66 | $122,387.76 | -24.8% | +20.5% | - | |
| Jan 2, 2025 | VCYT Veracyte, Inc. | Director | Sale+OE | 10,000 | $40.30 | $403,005.64 | -19.3% | -25.5% | +4.8% | |
| Nov 19, 2024 | VCYT Veracyte, Inc. | Director | Sell | 14,731 | $38.34 | $564,768.40 | -15.8% | +3.2% | +2.0% | |
| Jul 16, 2024 | VCYT Veracyte, Inc. | Director | Sell | 7,500 | $25.00 | $187,500.00 | -18.4% | +32.7% | -1.5% | |
| Jun 11, 2024 | VCYT Veracyte, Inc. | Director | Sell | 3,870 | $20.59 | $79,683.30 | -11.7% | +36.6% | +31.2% | |
| Jun 7, 2024 | VCYT Veracyte, Inc. | Director | Sale+OE | 2,500 | $20.97 | $52,425.00 | -7.0% | +44.2% | +33.0% | |
| Apr 1, 2024 | VCYT Veracyte, Inc. | Director | Sale+OE | 10,000 | $21.65 | $216,528.00 | -23.2% | -1.4% | +36.6% | |
| Mar 16, 2023 | VCYT Veracyte, Inc. | Director | Sale+OE | 18,750 | $22.78 | $427,044.38 | -44.4% | +13.3% | -9.5% |